MODULE 1: Prevalence
Venous thromboembolism (VTE) represents one of the most important causes of morbidity and mortality in cancer patients
This module examines the prevalence of venous thromboembolism (VTE) in cancer patients, including sites and incidence of VTE among those undergoing surgical treatment or chemotherapy.
The module explores the scope of the problem and the variety of risk factors that impact on VTE rates. An overview will also be given of the burden of cancer-associated thrombosis in terms of increased morbidity and mortality.
The module will conclude with a 10-part MCQ online self-assessment. The ‘pass’ rate is 80% (8/10).
Please fill out the following form with your login credentials:
This website is intended to provide non-promotional, educational information to an international healthcare professional audience only.
You have indicated that you are not a healthcare professional and therefore, do not have access to this site.Please click here to continue browsing